TILT Holdings (TLLTF) Liabilities and Shareholders Equity (2021 - 2025)

TILT Holdings (TLLTF) reported Liabilities and Shareholders Equity of $138.3 million for Q2 2025, down 27.19% on a YoY basis from $189.9 million in Q2 2024, and down 7.65% quarter-over-quarter from $149.7 million in Q1 2025.

TILT Holdings (TLLTF) Liabilities and Shareholders Equity (2021 - 2025) Analysis & Trends

TILT Holdings has reported Liabilities and Shareholders Equity for 5 years, with the latest figure at $138.3 million in Q2 2025.

  • For the quarter ending Q2 2025, Liabilities and Shareholders Equity fell 27.19% year-over-year to $138.3 million; the trailing twelve-month figure through Jun 2025 stood at $621.9 million (down 31.21% YoY), and the FY2024 full-year result was $151.3 million, down 34.55% from the prior year.
  • Liabilities and Shareholders Equity for Q2 2025 stood at $138.3 million, down from $149.7 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $401.2 million in Q2 2022, with the low at $138.3 million in Q2 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $251.1 million across 5 years, with a median of $241.5 million in 2023.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity sank 35.64% — and 2024, when it dropped 19.97%.
  • TILT Holdings' Liabilities and Shareholders Equity stood at $381.3 million in 2021, then retreated by 22.91% to $294.0 million in 2022, then declined by 21.36% to $231.2 million in 2023, then sank by 34.55% to $151.3 million in 2024, then dropped by 8.61% to $138.3 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $138.3 million (Q2 2025), $149.7 million (Q1 2025), and $151.3 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 TILT Holdings - - 1.82 Mn 138.29 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 138.29 Mn
Mar 31, 2025 149.74 Mn
Dec 31, 2024 151.32 Mn
Sep 30, 2024 182.59 Mn
Jun 30, 2024 189.92 Mn
Mar 31, 2024 231.83 Mn
Dec 31, 2023 231.19 Mn
Sep 30, 2023 251.23 Mn
Jun 30, 2023 258.22 Mn
Mar 31, 2023 289.68 Mn
Dec 31, 2022 293.98 Mn
Sep 30, 2022 364.38 Mn
Jun 30, 2022 401.19 Mn
Dec 31, 2021 381.35 Mn